Toll-like receptor 9 expression is associated with breast cancer sensitivity to the growth inhibitory effects of bisphosphonates in vitro and in vivo

Bisphosphonates are standard treatments for bone metastases. When given in the adjuvant setting, they reduce breast cancer mortality and recurrence in bone but only among post-menopausal patients. Optimal drug use would require biomarker-based patient selection. Such biomarkers are not yet in clinic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Sandholm, Jouko, Lehtimäki, Jaakko, Ishizu, Tamiko, Velu, Sadanandan E., Clark, Jeremy, Härkönen, Pirkko, Jukkola-Vuorinen, Arja, Schrey, Aleksi, Harris, Kevin W., Tuomela, Johanna M., Selander, Katri S.
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5349995/
https://ncbi.nlm.nih.gov/pubmed/27888633
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13570
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados